CD8A and neoplasm: As expected, the enhanced tumor regressions by combined therapy of VC and anti-PD-L1 coincided with increased infiltration of intratumoral CD8+ cytotoxic T cells in IgG Ctrl groups (Supplementary Fig. 15c–e).